1. |
Schievano S, Coats L, Migliavacca F, et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson, 2007, 9(4): 687-695.
|
2. |
Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet, 2000, 356(9239): 1403-1405.
|
3. |
Georgiev S, Ewert P, Eicken A, et al. Munich comparative study: prospective long-term outcome of the transcatheter melody valve versus surgical pulmonary bioprosthesis with up to 12 years of follow-up. Circ Cardiovasc Interv, 2020, 13(7): e008963.
|
4. |
Ribeiro JM, Teixeira R, Lopes J, et al. Transcatheter versus surgical pulmonary valve replacement: a systemic review and meta-analysis. Ann Thorac Surg, 2020, 110(5): 1751-1761.
|
5. |
Baumgartner H, De Backer J. The ESC clinical practice guidelines for the management of adult congenital heart disease 2020. Eur Heart J, 2020, 41(43): 4153-4154.
|
6. |
Lurz P, Kister T. Why we need another percutaneous pulmonary valve: if size matters. EuroIntervention, 2019, 14(13): 1347-1349.
|
7. |
Capelli C, Taylor AM, Migliavacca F, et al. Patient-specific reconstructed anatomies and computer simulations are fundamental for selecting medical device treatment: application to a new percutaneous pulmonary valve. Philos Trans A Math Phys Eng Sci, 2010, 368(1921): 3027-3038.
|
8. |
Zhou D, Pan W, Jilaihawi H, et al. A self-expanding percutaneous valve for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract: one-year results. EuroIntervention, 2019, 14(13): 1371-1377.
|